Leukotriene receptor antagonists in asthma therapy
- 1 January 2003
- journal article
- review article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 111 (1), S62-S70
- https://doi.org/10.1067/mai.2003.21
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Do Inhaled Corticosteroids Affect Perception of Dyspnea During Bronchoconstriction in Asthma?Chest, 2001
- Low-dose fluticasone propionate compared with montelukast for first-line treatment of persistent asthma: A randomized clinical trialJournal of Allergy and Clinical Immunology, 2001
- Effect of leukotriene receptor antagonist therapy on the risk of asthma exacerbations in patients with mild to moderate asthma: an integrated analysis of zafirlukast trialsThorax, 2000
- Airway–Parenchyma Uncoupling in Nocturnal AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Lymphocyte and Eosinophil Influx into Alveolar Tissue in Nocturnal AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 1999
- Zafirlukast improves asthma symptoms and quality of life in patients with moderate reversible airflow obstructionJournal of Allergy and Clinical Immunology, 1998
- Zafirlukast for symptomatic mild-to-moderate asthma: a 13-week multicenter studyClinical Therapeutics, 1997
- Persistent increase in plasma and urinary leukotrienes after acute asthma.Archives of Disease in Childhood, 1995
- Peripheral Lung Resistance in Normal and Asthmatic SubjectsAmerican Review of Respiratory Disease, 1990
- Effects of Leukotriene D on the Airways in AsthmaNew England Journal of Medicine, 1983